文献速递胃肠动力与功能性疾病

个性化FODMAP饮食与NICE饮食建议对IBS症状控制的随机对照试验

Effects of a Personalised FODMAP Diet Versus the National Institute for Health and Care Excellence (NICE) Dietary Advice on Symptom Control in Patients With Irritable Bowel Syndrome: Randomised Clinical Trial.
PubMed 文献 · Aliment Pharmacol Ther · 2026-03-05

这项平行组随机临床试验将符合Rome III标准的成人IBS患者按1:1分配接受NICE饮食建议或个性化FODMAP饮食(选择性减少50%患者特异性高FODMAP食物)4周。两组均显著减少热量摄入并改善症状严重程度,特别是腹痛、腹胀、便秘和腹泻;NICE组充分缓解率41.2%,个性化FODMAP组54.5%(p=0.33),组间无显著差异。结论是个性化、限制性更少的FODMAP饮食可获得与NICE饮食建议相当的 symptomatic改善,同时保持营养充足性。

要点

  • 个性化FODMAP饮食通过结构化饮食日记选择性减少50%患者特异性高FODMAP食物,限制性更少。
  • 两组均显著改善腹痛、腹胀、便秘和腹泻等症状严重程度。
  • 充分缓解率组间无显著差异(NICE组41.2% vs 个性化FODMAP组54.5%,p=0.33)。

核心结论

  • 个性化、限制性更少的FODMAP饮食在IBS症状改善方面与NICE饮食建议相当,且可能提高可行性和长期依从性。

主要发现

  • 两组干预均显著减少热量摄入并改善症状严重程度,尤其是腹痛、腹胀、便秘和腹泻。
  • 充分缓解(腹痛和排便习惯均改善≥1分,4点Likert量表)在NICE组为41.2%,个性化FODMAP组为54.5%(p=0.33),组间无显著差异。
  • 基线人口学、人体测量学变量和IBS亚型在两组间相似。

关键数值与推荐

  • 个性化FODMAP饮食为通过结构化食物和症状日记识别患者特异性高FODMAP食物后选择性减少50%。
  • 充分缓解定义为腹痛和排便习惯均改善≥1分(4点Likert量表)。

临床怎么用

  • 对于IBS患者,可考虑采用个性化、限制性更少的FODMAP饮食作为NICE饮食建议的替代方案,以提高可行性和长期依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Irritable bowel syndrome is a disorder of the gut-brain interaction characterised by chronic abdominal pain and altered bowel habits, with substantial impact on quality of life. Symptoms are associated with foods trigger, leading to specific dietary interventions. Adherence and acceptability may improve when dietary interventions are personalised and less restrictive. While the low-FODMAP diet is effective, its restrictiveness may limit long-term adherence. Personalised dietary strategies may offer comparable benefit with greater feasibility. METHODS: In this parallel-group, randomised clinical trial, adults fulfilling Rome III criteria for IBS were assigned (1:1) to NICE dietary advice or an personalised FODMAP diet for four weeks. The personalised diet involved selective 50% reduction of patient-specific high-FODMAP foods identified through structured food and symptom diaries. Symptoms were evaluated using a 4-point Likert scale, with adequate relief defined as ≥ 1-point improvement in both abdominal pain and bowel habits. Dietary intake, quality of life (SF-36) and anthropometric measures were recorded at baseline and follow-up. RESULTS: Sixty-nine participants were enrolled (85% women; mean age 39.9 ± 12.2 years). Baseline demographics, anthropometric variables and IBS subtypes were similar across groups. Both interventions significantly reduced caloric intake and improved symptom severity, particularly abdominal pain, distension, constipation and diarrhoea. Adequate relief occurred in 41.2% of the NICE group and 54.5% of the personalised FODMAP group (p = 0.33). No significant between-group differences were observed. CONCLUSIONS: An individualised, less restrictive personalised FODMAP diet yields symptom improvement comparable to NICE dietary advice while preserving nutritional adequacy. Personalised dietary strategies may enhance feasibility and long-term adherence in IBS management.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Garcia-Cedillo MF, Huerta-de la Torre MF, Arenas-Martinez JS, et al. Effects of a Personalised FODMAP Diet Versus the National Institute for Health and Care Excellence (NICE) Dietary Advice on Symptom Control in Patients With Irritable Bowel Syndrome: Randomised Clinical Trial. Aliment Pharmacol Ther. 2026. PMID: 41784137. doi:10.1111/apt.70601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。